183 related articles for article (PubMed ID: 10925313)
1. Autoantigen-specific CD4+CD28low T cell subset prevents autoimmune exocrinopathy in murine Sjögren's syndrome.
Saegusa K; Ishimaru N; Yanagi K; Haneji N; Nishino M; Azuma M; Saito I; Hayashi Y
J Immunol; 2000 Aug; 165(4):2251-7. PubMed ID: 10925313
[TBL] [Abstract][Full Text] [Related]
2. Treatment with anti-CD86 costimulatory molecule prevents the autoimmune lesions in murine Sjögren's syndrome (SS) through up-regulated Th2 response.
Saegusa K; Ishimaru N; Yanagi K; Haneji N; Nishino M; Azuma M; Saito I; Hayashi Y
Clin Exp Immunol; 2000 Feb; 119(2):354-60. PubMed ID: 10632675
[TBL] [Abstract][Full Text] [Related]
3. Prevention and induction of autoimmune exocrinopathy is dependent on pathogenic autoantigen cleavage in murine Sjögren's syndrome.
Saegusa K; Ishimaru N; Yanagi K; Mishima K; Arakaki R; Suda T; Saito I; Hayashi Y
J Immunol; 2002 Jul; 169(2):1050-7. PubMed ID: 12097413
[TBL] [Abstract][Full Text] [Related]
4. Development of autoimmune exocrinopathy resembling Sjögren's syndrome in adoptively transferred mice with autoreactive CD4+ T cells.
Arakaki R; Ishimaru N; Saito I; Kobayashi M; Yasui N; Sumida T; Hayashi Y
Arthritis Rheum; 2003 Dec; 48(12):3603-9. PubMed ID: 14674013
[TBL] [Abstract][Full Text] [Related]
5. Possible role of organ-specific autoantigen for Fas ligand-mediated activation-induced cell death in murine Sjögren's syndrome.
Ishimaru N; Yanagi K; Ogawa K; Suda T; Saito I; Hayashi Y
J Immunol; 2001 Nov; 167(10):6031-7. PubMed ID: 11698484
[TBL] [Abstract][Full Text] [Related]
6. Anti-120-kDa alpha-fodrin immune response with Th1-cytokine profile in the NOD mouse model of Sjögren's syndrome.
Yanagi K; Ishimaru N; Haneji N; Saegusa K; Saito I; Hayashi Y
Eur J Immunol; 1998 Oct; 28(10):3336-45. PubMed ID: 9808203
[TBL] [Abstract][Full Text] [Related]
7. Development of autoimmune arthritis with aging via bystander T cell activation in the mouse model of Sjögren's syndrome.
Kobayashi M; Yasui N; Ishimaru N; Arakaki R; Hayashi Y
Arthritis Rheum; 2004 Dec; 50(12):3974-84. PubMed ID: 15593201
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of neonatal tolerance induced in an animal model for primary Sjögren's syndrome by intravenous administration of autoantigen.
Saegusa K; Ishimaru N; Haneji N; Yanagi K; Yoneda T; Saito I; Hayashi Y
Scand J Immunol; 2000 Sep; 52(3):264-70. PubMed ID: 10972902
[TBL] [Abstract][Full Text] [Related]
9. Identification of alpha-fodrin as a candidate autoantigen in primary Sjögren's syndrome.
Haneji N; Nakamura T; Takio K; Yanagi K; Higashiyama H; Saito I; Noji S; Sugino H; Hayashi Y
Science; 1997 Apr; 276(5312):604-7. PubMed ID: 9110981
[TBL] [Abstract][Full Text] [Related]
10. The role of caspase cascade on the development of primary Sjögren's syndrome.
Hayashi Y; Arakaki R; Ishimaru N
J Med Invest; 2003 Feb; 50(1-2):32-8. PubMed ID: 12630566
[TBL] [Abstract][Full Text] [Related]
11. Severe destructive autoimmune lesions with aging in murine Sjögren's syndrome through Fas-mediated apoptosis.
Ishimaru N; Yoneda T; Saegusa K; Yanagi K; Haneji N; Moriyama K; Saito I; Hayashi Y
Am J Pathol; 2000 May; 156(5):1557-64. PubMed ID: 10793067
[TBL] [Abstract][Full Text] [Related]
12. Analysis of in vivo role of alpha-fodrin autoantigen in primary Sjogren's syndrome.
Miyazaki K; Takeda N; Ishimaru N; Omotehara F; Arakaki R; Hayashi Y
Am J Pathol; 2005 Oct; 167(4):1051-9. PubMed ID: 16192640
[TBL] [Abstract][Full Text] [Related]
13. Characterization of a new regulatory CD4+ T cell subset in primary Sjögren's syndrome.
Alunno A; Petrillo MG; Nocentini G; Bistoni O; Bartoloni E; Caterbi S; Bianchini R; Baldini C; Nicoletti I; Riccardi C; Gerli R
Rheumatology (Oxford); 2013 Aug; 52(8):1387-96. PubMed ID: 23674818
[TBL] [Abstract][Full Text] [Related]
14. Mucosal administration of alpha-fodrin inhibits experimental Sjögren's syndrome autoimmunity.
He J; Zhao J; Li Z
Arthritis Res Ther; 2008; 10(2):R44. PubMed ID: 18419828
[TBL] [Abstract][Full Text] [Related]
15. Development of autoimmune exocrinopathy resembling Sjögren's syndrome in estrogen-deficient mice of healthy background.
Ishimaru N; Arakaki R; Watanabe M; Kobayashi M; Miyazaki K; Hayashi Y
Am J Pathol; 2003 Oct; 163(4):1481-90. PubMed ID: 14507655
[TBL] [Abstract][Full Text] [Related]
16. Possible involvement of EBV-mediated alpha-fodrin cleavage for organ-specific autoantigen in Sjogren's syndrome.
Inoue H; Tsubota K; Ono M; Kizu Y; Mizuno F; Takada K; Yamada K; Yanagi K; Hayashi Y; Saito I
J Immunol; 2001 May; 166(9):5801-9. PubMed ID: 11313424
[TBL] [Abstract][Full Text] [Related]
17. The role of M3 muscarinic acetylcholine receptor reactive T cells in Sjögren's syndrome: a critical review.
Sumida T; Tsuboi H; Iizuka M; Hirota T; Asashima H; Matsumoto I
J Autoimmun; 2014 Jun; 51():44-50. PubMed ID: 24397962
[TBL] [Abstract][Full Text] [Related]
18. Effector mechanism of experimental autoimmune sialadenitis in the mouse model for primary Sjögren's syndrome.
Hayashi Y; Haneji N; Hamano H; Yanagi K; Takahashi M; Ishimaru N
Cell Immunol; 1996 Aug; 171(2):217-25. PubMed ID: 8806790
[TBL] [Abstract][Full Text] [Related]
19. Induction of autoantigen-specific Th2 and Tr1 regulatory T cells and modulation of autoimmune diabetes.
Chen C; Lee WH; Yun P; Snow P; Liu CP
J Immunol; 2003 Jul; 171(2):733-44. PubMed ID: 12847240
[TBL] [Abstract][Full Text] [Related]
20. Induction of CD4 T cell changes in murine AIDS is dependent on costimulation and involves a dysregulation of homeostasis.
Yen MH; Lepak N; Swain SL
J Immunol; 2002 Jul; 169(2):722-31. PubMed ID: 12097374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
